CoChat

Novel roles of DC-SIGNR in colon cancer cell adhesion, migration, invasion, and liver metastasis

Open access
Na, Heya, Liu, Xiaoli, Li, Xiaomeng, Zhang, Xinsheng, Wang, Yu, Wang, Zhaohui, Yuan, Menglang, Zhang, Yu, Ren, Shuangyi, Zuo, Yunfei · 2017 · Journal of Hematology & Oncology
Cited by 52

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Tumor metastasis is an essential cause of the poor prognosis of colon cancer. DC-SIGNR is a C-type lectin that is frequently found on human liver sinusoidal endothelial cells. LSECtin, which is a homologue of DC-SIGNR, has been demonstrated to participate in colon cancer liver metastasis. Due to the similarities in the expression pattern and structure of the two proteins, we speculated that DC-SIGNR could also be involved in this process. METHODS: Colon cancer cells were treated with the DC-SIGNR protein or control IgG, after which cell migration, invasion, and morphology were assayed. Xenograft mouse models were used to determine the role of DC-SIGNR in colon cancer liver metastasis in vivo. In addition, a human gene expression array was used to detect differential gene expression in colon cancer cells stimulated with the DC-SIGNR protein. The serum level of DC-SIGNR was examined in colon cancer patients by ELISA, and the significance of DC-SIGNR was determined. RESULTS: In our research, we investigated whether DC-SIGNR promotes colon cancer cell adhesion, migration, and invasion. Knocking down mouse DC-SIGNR decreased the liver metastatic potency of colon cancer cells and increased survival time. Expressing human DC-SIGNR enhanced colon cancer liver metastasis. Furthermore, DC-SIGNR conferred metastatic capability on cancer cells by upregulating various metallothionein isoforms. To validate the above results, we also found that the serum DC-SIGNR level was statistically higher in colon cancer patients with liver metastasis compared with those without metastasis. CONCLUSIONS: These results imply that DC-SIGNR may promote colon carcinoma hepatic metastasis and could serve as a promising therapeutic target for anticancer treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13045-016-0383-x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Crossing the endothelial barrier during metastasis

    Reymond, N., d'Água, B. B., & Ridley, A. J. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3628 · Cited by 922 · cited 1×

    “From the perspective of the organ microenvironment, both the vessel diameter of capillary walls and the structural composition of blood vessels can affect tumour cell infiltration [4, 5].”
    Background

Show all 1 references

Cited by

See all 52

Metadata

Authors
Na, H., Liu, X., Li, X., Zhang, X., Wang, Y., Wang, Z., Yuan, M., Zhang, Y., Ren, S., & Zuo, Y.
Venue
Journal of Hematology & Oncology
Published
2017-01-21
Volume
10
Issue
1
Pages
28-28
ISSN
1756-8722 (ISSN-L)
OpenAlex
W2572270369
Cited by
52
References
1
FWCI
2.33
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Novel roles of DC-SIGNR in colon cancer cell adhesion, migration, invasion, and liver metastasis. https://app.cochat.ai/papers/10.1186/s13045-016-0383-x
The paper
Na, H., Liu, X., Li, X., Zhang, X., Wang, Y., Wang, Z., Yuan, M., Zhang, Y., Ren, S., & Zuo, Y. (2017). Novel roles of DC-SIGNR in colon cancer cell adhesion, migration, invasion, and liver metastasis. Journal of Hematology & Oncology. https://doi.org/10.1186/s13045-016-0383-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.